Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles

Leukemia

Volumn 14, Issue 1, 2000, Pages 142-152

  Uozumi, K ^a   Otsuka, M ^a   Ohno, N ^a   Moriyama, T ^a   Suzuki, S ^a   Shimotakahara, S ^a   Matsumura, J ^b   Hanada, S ^a   Arima, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

ET; Megakaryoblastic cell line; Platelet like particles; SET 2

Indexed keywords

BETA THROMBOGLOBULIN; C MPL; CD33 ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD61 ANTIGEN; CD7 ANTIGEN; CD71 ANTIGEN; FIBRINOGEN RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; THROMBOCYTE FACTOR 4; THROMBOPOIETIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CELL LINE; CELL MATURATION; FEMALE; HUMAN; HUMAN CELL; MEGAKARYOBLAST; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0033967383     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401608     Document Type: Article

References (53)

1. Fugman DA, Witte DP, Jones CLA, Aronow BJ, Lieberman MA. In vitro establishment and characterization of a human megakaryoblastic cell line. Blood 1990; 75: 1252-1261.
2. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 1985; 66: 1384-1392.
3. Sato T, Fuse A, Eguchi M, Hayashi Y, Ryo R, Adachi M, Kishimoto Y, Teramura M, Mizoguchi H, Shima Y, Komori I, Sunami S, Okimoto Y, Nakajima H. Establishment of a human leukemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastk leukaemia. Br J Haematol 1989; 72: 184-190.
4. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang Y-C, Pegoraro L, Clark SC. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 1990; 145: 458-464.
5. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 1991; 51: 341-348.
6. Takeuchi S, Sugito S, Uemura Y, Miyagi T, Kubonish I, Taguchi H, Enzan H, Ohtsuki Y, Miyoshi I. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo. Leukemia 1992; 6: 588-594.
7. Mouthon MA, Freund M, Titeux M, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis. Blood 1994; 84: 1085-1097.
8. Abe A, Emi N, Kato H, Adachi K, Murate T, Saga S, Ogura M, Kojima T, Tanimoto M, Morishita N, Kawashima K, Saito H. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2. Leukemia 1995; 9: 341-349.
9. Tsuyuoka R, Takahashi T, Suzuki A, Sasaki Y, Nakamura K, Fukumoto M, Ohmori K, Ohno Y, Nakao K. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Stem Cells 1995; 13: 54-64.
10. Allen RJ, Smith SD, Moldwin RL, Lu MM, Giordano L, Vignon C, Suto Y, Harden A, Tomek R, Veldman T, Ried T, Larson RA, Le Beau MM, Rowley JD, Zeleznik-Le N. Establishment and characterization of a megakaryoblast cell line with amplification of MLL. Leukemia 1998; 12: 1119-1127.
11. Matsumura I, Kanakura Y, Kato T, Ikeda H, Ishikawa J, Horikawa Y, Hashimoto K, Moriyama Y, Tsujimura T, Nishiura T, Miyazaki H, Matsuzawa Y. Growth response of acute myeloblaslic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703-709.
12. Drexler HG, Quentmeier H. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia 1996; 10: 1405-1421.
13. Drexler HG, Zaborski M, Quentmeier H. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines. Leukemia 1996; 11: 541-551.
14. Matsumura I, Kanakura Y, Ikeda H, Ishikawa J, Yoshida H, Horikawa Y, Nishiura T, Tahara T, Kato T, Miyazaki H, Matsuzawa Y. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Leukemia 1996; 10: 91-94.
15. Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Yasusada M. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood 1996; 87: 4552-4560.
16. Takeuchi K, Ogura M, Saito H, Satoh M, Takeuchi M. Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01). Exp Cell Res 1991; 193: 223-226.
17. Murphy S, Iland H, Rosenthal D, Laszol J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986; 23: 177-182.
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
19. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samel B, Nichol JL, Swift S, Johonson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Choi E, Pangelinan M, Sun Y, Mar V, McNinch MJ, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sleu L, Padilla D, Trail C, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Castillo JD, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 1994; 77: 1117-1124.
20. ISCN (1995). Mitelman F (ed). An international system for human cytogenetic nomenclature. S Karger: Basel, 1995.
21. Chang KL, Chen YY, Shibata D, Weiss I M. Description of an in-situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissue. Diagn Mol Pathol 1992; 1: 246-255.
22. Jeffreys AJ, Turner M, Debenham P. The efficiency of multilocus DNA fingerprint probes for individualization and establishment of family relationships, determined from extensive casework. Am J Hum Genet 1991; 48: 824-840.
23. Häne B, Tümmler M, Jäger K, Schleithoff L, Janssen JWG, Drexler HG. Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources. Leukemia 1992; 6: 1129-1133.
24. MacLeod RAF, Dirks WG, Reid YA, Hay RJ, Drexler HG. Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting. Leukemia 1997; 11: 2032-2038.
25. Tahara T, Usuki K, Sato H, Ohashi H, Morita H, Tsumura H, Matsumoto A, Miyazaki H, Urabe A, Kato T. A sensitive' sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol 1996; 93: 785-788.
26. Kato T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y. Akahori H, Horie K, Kokubo A, Kudo Y, Maeda E, Kobayashi K, Ohashi H, Ozawa T, Inoue H, Kawamura K, Miyazaki H. Purification and characterization of thrombopoietin. J Biochem 1995; 118: 229-236.
27. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma tell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497-499.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival. Application to proliteration and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
29. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159: 548-553.
30. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
31. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995; 85: 402-413.
32. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 460-462.
33. Yoshida H, Kondo M, Ichihashi T, Hashimoto N, Inazawa J, Ohno R, Naoe T. A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification. Cancer Genet Cytogenet 1998; 100: 21-24.
34. Hassan HT, Freund M. Review of megakaryoblastic cell lines. Characteristic biological features of human megakaryoblastic leukemia cell lines. Leukemia Res 1995; 19: 589-594.
35. Komatsu N, Suda T, Moroi M, Tokuyama N, Sakata Y, Okada M, Nishida T, Hirai Y, Sato T, Fuse A, Miura Y. Growth and differentiation of a human megakaryoblastic cell line, CMK. Blood 1989; 74: 42-48.
36. Nagano T, Ohga S, Kishimoto Y, Kimura T, Yasunaga K, Adachi M, Ryo R, Sato T. Ultrastructural analysis of platelet-like particles from a human megakaryocytic leukemia cell line (CMK 11-5). Int J Hematol 1992; 56: 67-78.
37. Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia 1996; 10: 297-310.
38. Takeuchi K, Satoh M, Kuno H, Yoshida T, Kondo H, Takeuchi M. Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01s. Br J Haematol 1998; 100: 436-444.
39. Rao AK, Carvalho ACA. Acquired qualitative platelet defects. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice 3rd edn. JB Lippincott Co: Philadelphia, 1994, pp 685-704.
40. Iwai K, Miyawaki T, Takazaki T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84: 1201-1208.
41. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86: 883-889.
42. Hu ZB, Ma W, Uphoff CC, Quentmeier H, Drexler HG. c-kit expression in human megakaryoblastic leukemia cell lines. Blood 1994; 83: 2133-2144.
43. Morita S, Tsuchiya S, Fujie H, Itano M, Ohashi Y, Minegishi M, Imaizumi M, Endo M, Takano N, Konno T. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture. Leiukemia 1996; 10: 102-105.
44. Adachi M, Rvo R, Sato T, Yamaguchi N. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK 11-5). Exp Hematol 1991; 19: 923-927.
45. Sasaki Y, Takahashi T, Tanaka I, Nakamura K, Okuno Y, Nakagawa O, Narumiya S, Nakao K. Expression of prostacyclin receptor in human megakaryocytes. Blood 1997; 90: 1039-1046.
46. Alexander WS, Metcalf D, Dunn AR. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 1995; 22: 5569-5578.
47. Onishi M, Mui AL-F, Morikawa Y, Cho L, Kinoshita S, Nolan GP, Gorman DM, Miyajima A, Kitamura T. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood 1996; 88: 1399-1406.
48. Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y. Markedly reduced expression of platelet c-mpl receptor in essential thromborythemia. Blood 1997; 90: 4031-4058.
49. Kiladjian JJ, Elkassar N, Hetet G, Briere J, Grandchamp B, Gardin C. Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia 1997; 11: 1821-1826.
50. Guerriero R, Testa U, Gabbianelli M, Mattia G, Montesoro E, Macioce G, Pace A, Ziegler B, Hassan HJ, Peschle C. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 1995; 86: 3725-3736.
51. Navarro S, Debili N, Le Couedic JP, Klein B, Breton-Gorius J, Doly J, Vainchenker W. Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood 1991; 77: 461-471.
52. Wickenhauser C, Lorenzen J, Thiele J, Hillienhof A, Jungheim K, Schmitz B, Hansmann ML, Fisher R. Secretion of cytokines (interleukin-1 α, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood 1995; 85: 685-691.
53. Fuse A, Kakuda H, Shima Y, Van Damme J, Billiau A, Sato T. Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br J Haematol 1991; 77: 32-36.